With more people turning to the internet or social media platforms as a ‘first point of call’, including for health purposes, whether that’s aftercare tips following surgery or advice on skin conditions from dermatologists, social media is playing a big part in how the public can access healthcare information.
UK consumers increasingly treat social media as a first port of call for health information, including symptom triage, treatment options, post-procedure care, and provider selection. The behaviour is not limited to younger demographics. Older audiences also use social channels for health content, often in the form of long-form video and curated medical commentary. The implication for healthcare brands and providers is that the consumer journey to a clinical decision now routinely starts somewhere other than a GP's office.
Which social platforms shape UK health behaviour?
Six platforms carry the bulk of UK consumer health content engagement. Facebook reaches the largest monthly audience overall, with over 2.2 billion users globally. YouTube follows with 1.9 billion. WhatsApp's 1.5 billion users sit predominantly in private group conversation. Instagram, with 1 billion users, is where visual treatment content and clinic-side promotion concentrates. TikTok at 500 million users is the fastest-growing for younger demographics, and Twitter at 350 million carries the bulk of policy and political health commentary.
The platform mix matters because each channel is structurally different. Information that travels on Facebook tends to be community-shared. Information on YouTube is creator-led and longer-form. Information on Instagram skews toward before-and-after visual content. Information on TikTok is short-form and creator-led, with a younger audience and higher rate of misinformation. A health communication strategy that treats social media as one channel will under-perform a strategy that treats each platform as its own discipline.
How are new platforms reshaping healthcare conversations?
Audio-led platforms have introduced a new format for health discussion. Clubhouse, launched as an invite-only audio chat platform, surfaced clusters of healthcare-focused communities almost immediately. The Healthcare Startups club alone has accumulated over 16,000 followers and 3,900 active members. Aesthetic and dermatology clubs run regular conversations covering injectables, laser treatments, post-operative care, and skincare.
These audio formats give consumers something the existing healthcare system does not: real-time access to clinical voices without booking an appointment. They listen on commutes, in workouts, while doing chores. The barrier between consumer and professional opinion is lower than at any point in the past, and the implications for health behaviour and provider selection are still working through.
Who are the UK healthcare social media voices that matter?
Different specialties have produced different kinds of social media voices. Dermatology has Dr Sandra Lee, the Dr Pimple Popper account, with 4.1 million Instagram followers, 6.93 million YouTube subscribers, and 45,500 Twitter followers. Plastic surgery has surgeons including Dr Julian De Silva building patient-facing follower bases, with educational and before-and-after content. Mental health has Dr Alex George, appointed by the UK government as Mental Health Ambassador, reaching 1.9 million followers on Instagram and 713,900 on TikTok.
The political and policy layer has its own influence map. Fergus Walsh at the BBC, Hugh Pym at BBC News, and Alastair McLellan at Health Service Journal between them shape the UK media narrative on NHS and private healthcare policy through Twitter alone. Healthcare brands that map only clinical voices and ignore the policy-media voices are missing half the influence picture.
What does this mean for healthcare brands and providers?
Three implications for commercial planning. First, the consumer journey to a healthcare decision now starts on social media for an increasing share of patients. Provider strategy that does not surface in those channels effectively does not exist for that audience. Second, the platform mix matters operationally. Different platforms reach different audiences with different content formats, and a single content production pipeline rarely lands well across all of them. Third, the trust signals consumers respond to are shifting. Visible regulatory body membership, clinical credentials, and consistent informational content matter more than glossy production values, particularly for healthcare-specific decisions.
The brands and providers that build for this environment, with platform-native content, credible clinical voices, and a clear separation from non-clinical content, are the ones consumers will find first when they go looking.
